Nile Therapeutics, Inc.
Nile Therapeutics, Inc. (NILT.OB) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 8 transactions totaling $10.7K, demonstrating a bullish sentiment with $10.7K in net insider flow. The most recent transaction on Apr 15, 2008 involved a purchase of 100 shares valued at $460.
NILT.OB Insider Activity Summary
Who Is Buying NILT.OB Stock?
No significant insider buying has been recorded for NILT.OB in the recent period.
Who Is Selling NILT.OB Stock?
No significant insider selling has been recorded for NILT.OB in the recent period.
Is Nile Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NILT.OB is bullish with an Insider Alignment Score of 100/100 and a net flow of $10.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NILT.OB Frequently Asked Questions
Understanding NILT.OB Insider Activity
Insider trading at Nile Therapeutics, Inc. (NILT.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading NILT.OB stock, having executed 8 transactions in the past 90 days. The most active insider is Peter M. Strumph (Executive), who has made 3 transactions totaling $6.6K.
Related Tools
Track Nile Therapeutics, Inc. Insider Activity
Get notified when executives and directors at NILT.OB file new Form 4 transactions